Cargando…
Metabolomic biomarkers in autism: identification of complex dysregulations of cellular bioenergetics
Autism Spectrum Disorder (ASD or autism) is a phenotypically and etiologically heterogeneous condition. Identifying biomarkers of clinically significant metabolic subtypes of autism could improve understanding of its underlying pathophysiology and potentially lead to more targeted interventions. We...
Autores principales: | Smith, Alan M., Donley, Elizabeth L. R., Ney, Denise M., Amaral, David G., Burrier, Robert E., Natowicz, Marvin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622772/ https://www.ncbi.nlm.nih.gov/pubmed/37928922 http://dx.doi.org/10.3389/fpsyt.2023.1249578 |
Ejemplares similares
-
A Metabolomics Approach to Screening for Autism Risk in the Children's Autism Metabolome Project
por: Smith, Alan M., et al.
Publicado: (2020) -
Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children
por: West, Paul R., et al.
Publicado: (2014) -
Editorial: Secondary vs. Idiopathic Autism
por: Casanova, Manuel F., et al.
Publicado: (2020) -
Cellular Bioenergetics and AMPK and TORC1 Signalling in Blood Lymphoblasts Are Biomarkers of Clinical Status in FMR1 Premutation Carriers
por: Loesch, Danuta Z., et al.
Publicado: (2021) -
Patterning of Regional Gene Expression in Autism: New Complexity
por: Ginsberg, Matthew R., et al.
Publicado: (2013)